Skip to content

Tinnitus Treatment Report

News
Research
Clinical Trials
Projects
Discussion

GW-TT23

News

Gateway Biotechnology Update on GW-TT2 (Nimodipine) & GW-TT5

News

Gateway Biotechnology Adds Three New Tinnitus Drugs to Pipeline: GW-TT2, GW-TT5, GW-TT23

Enter your email address

Email

This field is for validation purposes and should be left unchanged.

Donate
Contact
Subscribe

Address

Urgent Research LLC
7207 N Shadeland Ave Suite C
Indianapolis, IN 46250

The content on this website is not a substitute for professional medical advice, diagnosis, or treatment. Never ignore professional medical advice or delay in seeking it because of something you have read on this website. Always talk to your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition. Any mention of products, services or companies is not meant as a guarantee, endorsement, or recommendation. This website is independent and unaffiliated. No conflicts of interest to disclose.

Copyright © 2025 Urgent Research LLC